Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin.
Satoshi
S
Nakamizo
Yoshiki
Y
Miyachi
Kenji
K
Kabashima
D000279:Administration, Cutaneous; D000588:Amines / Q000008:administration & dosage*; D000700:Analgesics / Q000008:administration & dosage*; D000982:Antipruritics / Q000008:administration & dosage*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008875:Middle Aged; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D016559:Tacrolimus / Q000008:administration & dosage*; D016896:Treatment Outcome; D014277:Trigeminal Neuralgia / Q000150:complications*; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage*
D000588:Amines; D000700:Analgesics; D000982:Antipruritics; D003509:Cyclohexanecarboxylic Acids; D007166:Immunosuppressive Agents; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D016559:Tacrolimus